Vascular Graft Market to Reach $8.14 Billion by 2030 | Growing CAGR of 4.98%

The global vascular graft market, a critical component in the surgical management of vascular diseases, is poised for significant growth, reaching a projected value of $8,138.68 million by 2030. With a market size of $4,993.64 million in 2020, the industry is experiencing a robust Compound Annual Growth Rate (CAGR) of 4.98% from 2021 to 2030.


𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/2435


Vascular grafting is done for the treatment of various vascular complications, such as coronary artery disease (CAD), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and pediatric congenital cardiovascular defects (CCDs). The high blood pressure, cholesterol deposition, cardiac injury, and infections are causative factors for vascular diseases. The diabetes, hypertension, obesity, alcohol consumption, and tobacco smoking are the risk factors for the vascular diseases. The synthetic vascular grafts are made up of expanded polytetrafluoroethylene, Dacron, and polyurethane. However, polyurethane is better able to match the compliance of native vasculature. Hemodialysis access grafts, endovascular aneurysm repair stent grafts, and peripheral vascular grafts are commonly used for vascular grafting procedures.

Factors that drive the growth of the vascular grafts market include rise in number of hospitals, increase geriatric population, and advancement in vascular surgeries. For instance, according to World Population Ageing 2019, a publication by United Nation's Department of Economic and Social Affairs (DESA), 703 million people are aged 65 years or over globally in 2019. Furthermore, surge of sedentary lifestyle and unhealthy food diet has contributed in the growth of market. Sedentary lifestyle is responsible for deposition of cholesterol in blood vessels.


𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/2435

𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐇𝐞𝐚𝐥𝐭𝐡:

Vascular grafts, a crucial surgical intervention redirecting blood flow within the body, are instrumental in addressing a spectrum of vascular diseases. From peripheral artery disease (PAD) to deep vein thrombosis (DVT), these grafts play a vital role in the treatment of conditions affecting the circulatory system.

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡:

◉ 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬: The global surge in vascular diseases, including atherosclerosis, pulmonary embolism, deep vein thrombosis, and cardiac disorders, propels the demand for vascular graft procedures.

◉ 𝐑𝐢𝐬𝐞 𝐢𝐧 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬: Cardiovascular diseases, a leading cause of mortality globally, drive the adoption of vascular grafts. According to the World Health Organization, approximately 17.9 million people succumbed to cardiovascular diseases in 2019.

◉ 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐍𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬: The expansion of healthcare infrastructure, marked by an increase in the number of hospitals and surgery centers, accelerates the diagnosis and treatment of vascular diseases.

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

✅ Technological Advancements: Ongoing advancements in vascular graft technologies offer enhanced treatment options, contributing to the market's growth.

✅ Prevalence of Cardiovascular Diseases: A substantial increase in ischemic heart disease and cardiovascular disorders underlines the urgency to develop innovative solutions and expand the use of vascular grafts.


𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/2435


𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬:
𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬: Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Grafts, Peripheral Vascular Graft

𝐑𝐚𝐰 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬: Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, Biosynthetic

𝐄𝐧𝐝 𝐔𝐬𝐞𝐫𝐬: Hospitals, Ambulatory Surgical Centers (ASCs)

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

➤ North America: Dominating the market, North America is a key player in the growth trajectory, driven by technological advancements and a high prevalence of cardiovascular diseases.

➤ Europe: Contributing significantly to market expansion, European countries such as Germany, France, the U.K., and Italy witness increased adoption of vascular graft procedures.

➤ Asia-Pacific: With rapid advancements in healthcare, Asia-Pacific emerges as a prominent region in the global market.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Major contributors to the global vascular graft market include med-electronics, inc., IntriCon Corporation, amplifon, Cochlear Ltd, William Demant Holding A/S, starkey hearing technologies, GN Store Nord A/S, American Hearing Aids, SONOVA., and WS Audiology.

𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

The Vascular Graft Market Report equips stakeholders with a comprehensive analysis, offering insights into market trends, growth strategies, and investment opportunities. As the industry evolves, stakeholders are well-positioned to navigate challenges and capitalize on the burgeoning opportunities in vascular healthcare.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

David Correa

Wilmington, Delaware, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.